Trastuzumab for the Treatment of Salivary Duct CarcinomaSewanti Limaye, Robert I. Haddad, Marshall R. Posner et al.|The Oncologist|2013Cited by 185
ALK fusions in the pan-cancer setting: another tumor-agnostic target?Aditya Shreenivas, Razelle Kurzrock, Ben George et al.|npj Precision Oncology|2023Cited by 89